UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

(Mark One)

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 29, 2013

 

OR

 

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____________ to _________________

 

Commission File Number 0-18655

 

EXPONENT, INC.

(Exact name of registrant as specified in its charter)

 

DELAWARE

77-0218904

(State or other jurisdiction of

(I.R.S. Employer Identification No.)

incorporation or organization)

 

149 COMMONWEALTH DRIVE, MENLO PARK, CALIFORNIA

94025

(Address of principal executive office)

(Zip Code)

 

(650) 326-9400

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    

Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer x Non-accelerated filer ¨ Smaller reporting company ¨

(Do not check if a smaller

reporting company)

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨  No x

 

As of April 26, 2013, the latest practicable date, the registrant had 13,185,158 shares of Common Stock, $0.001 par value per share, outstanding.

 

 

EXPONENT, INC.

FORM 10-Q

 

TABLE OF CONTENTS

 

		Page
PART I – FINANCIAL INFORMATION
Item 1.	Financial Statements (unaudited):
	Condensed Consolidated Balance Sheets
	March 29, 2013 and December 28, 2012	4
	Condensed Consolidated Statements of Income
	Three Months Ended March 29, 2013 and March 30, 2012	5
	Condensed Consolidated Statements of Comprehensive Income
	Three Months Ended March 29, 2013 and March 30, 2012	6
	Condensed Consolidated Statements of Cash Flows
	Three Months Ended March 29, 2013 and March 30, 2012	7
	Notes to Unaudited Condensed Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	23
Item 4.	Controls and Procedures	24
PART II – OTHER INFORMATION
Item 1A.	Risk Factors	24
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	24
Item 6.	Exhibits	25
Signatures		26

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

EXPONENT, INC.

 

Condensed Consolidated Balance Sheets

 

March 29, 2013 and December 28, 2012

(in thousands, except par value)

(unaudited)

 

		March 29,				December 28,
		2013				2012
Assets
Current assets:
Cash and cash equivalents		$	101,501			$	113,268
Short-term investments			9,541				20,881
Accounts receivable, net of allowance for doubtful accounts
of $2,639 and $2,666 at March 29, 2013 and
December 28, 2012, respectively			80,552				85,361
Prepaid expenses and other assets			6,829				8,277
Deferred income taxes			8,222				7,657
Total current assets			206,645				235,444
Property, equipment and leasehold improvements, net			28,256				27,446
Goodwill			8,607				8,607
Deferred income taxes			19,319				18,359
Deferred compensation plan assets			31,469				24,801
Other assets			679				760
Total assets		$	294,975			$	315,417
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued liabilities		$	7,006			$	10,386
Accrued payroll and employee benefits			30,411				54,720
Deferred revenues			5,428				6,665
Total current liabilities			42,845				71,771
Other liabilities			1,045				988
Deferred compensation			31,377				24,697
Deferred rent			1,593				1,532
Total liabilities			76,860				98,988
Stockholders’ equity:
Common stock, $0.001 par value; 100,000 shares authorized;
16,427 shares issued at March 29, 2013 and December 28, 2012			16				16
Additional paid-in capital			137,199				123,693
Accumulated other comprehensive loss
Investment securities, available for sale			12				24
Foreign currency translation adjustments			(735	)			(274	)
			(723	)			(250	)
Retained earnings			201,917				206,057
Treasury stock, at cost; 3,209 and 3,221 shares held at
March 29, 2013 and December 28, 2012, respectively			(120,294	)			(113,087	)
Total stockholders’ equity			218,115				216,429
Total liabilities and stockholders’ equity		$	294,975			$	315,417

 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.

  

 

EXPONENT, INC.

 

Condensed Consolidated Statements of Income

 

For the Three Months Ended March 29, 2013 and March 30, 2012

(in thousands, except per share data)

(unaudited)

		Three Months Ended
		March 29, 2013				March 30, 2012
Revenues:
Revenues before reimbursements		$	68,992			$	66,470
Reimbursements			3,668				5,455
Revenues			72,660				71,925
Operating expenses:
Compensation and related expenses			48,562				46,175
Other operating expenses			6,147				5,562
Reimbursable expenses			3,668				5,455
General and administrative expenses			3,432				2,917
Total operating expenses			61,809				60,109
Operating income			10,851				11,816
Other income, net:
Interest income, net			45				77
Miscellaneous income, net			2,609				1,840
Total other income, net			2,654				1,917
Income before income taxes			13,505				13,733
Income taxes			5,529				5,532
Net income		$	7,976			$	8,201
Net income per share:
Basic		$	0.58			$	0.59
Diluted		$	0.56			$	0.57
Shares used in per share computations:
Basic			13,667				13,859
Diluted			14,125				14,419

 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements

 

 

EXPONENT, INC.

 

Condensed Consolidated Statements of Comprehensive Income

 

For the Three Months Ended March 29, 2013 and March 30, 2012

(in thousands)

(unaudited)

 

		Three Months Ended
		March 29, 2013				March 30, 2012
Net income		$	7,976			$	8,201
Other comprehensive income:
Foreign currency translation
adjustments, net of tax			(461	)			188
Unrealized (losses) gains on investments arising during the period,
net of tax			(12	)			26
Comprehensive income		$	7,503			$	8,415

 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.

 

 

EXPONENT, INC.

 

Condensed Consolidated Statements of Cash Flows

 

For the Three Months Ended March 29, 2013 and March 30, 2012

(in thousands)

(unaudited)

 

		Three Months Ended
		March 29, 2013				March 30, 2012
Cash flows from operating activities:
Net income		$	7,976			$	8,201
Adjustments to reconcile net income to net cash used in
operating activities:
Depreciation and amortization of property, equipment and
leasehold improvements			1,149				1,144
Amortization of premiums and accretion of discounts on
short-term investments			79				145
Deferred rent			61				(89	)
Provision for doubtful accounts			135				298
Stock-based compensation			5,291				4,457
Deferred income tax provision			(1,254	)			(600	)
Tax benefit for stock plans			(3,774	)			(2,435	)
Changes in operating assets and liabilities:
Accounts receivable			4,674				(1,334	)
Prepaid expenses and other assets			(3,121	)			2,240
Accounts payable and accrued liabilities			240				3,555
Accrued payroll and employee benefits			(15,401	)			(16,174	)
Deferred revenues			(1,237	)			(807	)
Net cash used in operating activities			(5,182	)			(1,399	)
Cash flows from investing activities:
Capital expenditures			(1,959	)			(1,294	)
Maturity of short-term investments			11,240				-
Net cash provided by (used in) investing activities			9,281				(1,294	)
Cash flows from financing activities:
Tax benefit for stock plans			3,774				2,435
Payroll taxes for restricted stock units			(6,119	)			(3,483	)
Repurchase of common stock			(11,490	)			(3,520	)
Exercise of share-based payment awards			612				1,088
Dividends paid			(1,969	)			-
Net cash used in financing activities			(15,192	)			(3,480	)
Effect of foreign currency exchange rates on cash and cash equivalents			(674	)			254
Net decrease in cash and cash equivalents			(11,767	)			(5,919	)
Cash and cash equivalents at beginning of period			113,268				84,439
Cash and cash equivalents at end of period		$	101,501			$	78,520

 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements.

 

 

EXPONENT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

For the Three Months Ended March 29, 2013 and March 30, 2012

 

Note 1: Basis of Presentation

 

Exponent, Inc. (referred to as the “Company” or “Exponent”) is an engineering and scientific consulting firm that provides solutions to complex problems. The Company operates on a 52-53 week fiscal year ending on the Friday closest to the last day of December.

 

The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission. Accordingly, they do not contain all the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments which are necessary for the fair presentation of the condensed consolidated financial statements have been included and all such adjustments are of a normal and recurring nature. The operating results for the three months ended March 29, 2013 are not necessarily representative of the results of future quarterly or annual periods. The following information should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2012 which was filed with the U.S. Securities and Exchange Commission on February 28, 2013.

 

The unaudited condensed consolidated financial statements include the accounts of Exponent, Inc. and its subsidiaries, which are all wholly owned. All intercompany accounts and transactions have been eliminated in consolidation.

 

Authorized Capital Stock. In a letter dated May 23, 2006, the Company committed to stockholders to limit its use of authorized capital stock to 40 million common shares, and 2 million preferred shares, unless the approval of the Company’s stockholders is subsequently obtained, such as through a further amendment to the Company’s authorized capital stock.

 

Dividend. On April 16, 2013, the Company declared a cash dividend of $0.15 per share of the Company’s common stock, payable June 28, 2013, to stockholders of record as of June 7, 2013. The Company expects to continue paying quarterly dividends in the future, subject to declaration of the Company’s Board of Directors.  

 

Recently Adopted Accounting Pronouncements.  In February, 2013, the Financial Accounting Standards Board (“FASB”) issued a new accounting standard for reporting of amounts reclassified out of accumulated other comprehensive income. The new standard does not change the current requirements for reporting net income or other comprehensive income in financial statements. However, the new standard requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under U.S. GAAP to be reclassified to net income in its entirety in the same reporting period. Effective December 29, 2012, the Company adopted this standard. There were no amounts reclassified from accumulated other comprehensive income to net income during the three months ended March 29, 2013.

 

Use of Estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.

 

 

Note 2: Fair Value Measurements

 

The Company measures certain financial assets and liabilities at fair value on a recurring basis, including available-for-sale fixed income securities, trading fixed income and equity securities held in its deferred compensation plan and the liability associated with its deferred compensation plan. There have been no transfers between fair value measurement levels during the quarters ended March 29, 2013 and March 30, 2012. Any transfers between fair value measurement levels would be recorded on the actual date of the event or change in circumstances that caused the transfer. The fair value of these certain financial assets and liabilities was determined using the following inputs at March 29, 2013:

 

		Fair Value Measurements at Reporting Date Using
(In thousands)		Total				Quoted Prices in Active Markets for Identical Assets (Level 1)				Significant Other Observable Inputs (Level 2)				Significant Unobservable Inputs (Level 3)
Assets
Money market
securities (1)		$	60,676			$	60,676			$	-			$	-
Fixed income available
for sale securities (2)			9,541				-				9,541				-
Fixed income trading
securities held in deferred
compensation plan (3)			14,360				14,360				-				-
Equity trading securities
held in deferred
compensation plan (3)			19,626				19,626				-				-
Total		$	104,203			$	94,662			$	9,541			$	-
Liabilities
Deferred compensation
plan (4)			33,894				33,894				-				-
Total		$	33,894			$	33,894			$	-			$	-

 

(1)

Included in cash and cash equivalents on the Company’s unaudited condensed consolidated balance sheet.

(2)

Included in short-term investments on the Company’s unaudited condensed consolidated balance sheet.

(3)

Included in other current assets and deferred compensation plan assets on the Company’s unaudited condensed consolidated balance sheet.

(4)

Included in accrued liabilities and deferred compensation on the Company’s unaudited condensed consolidated balance sheet.

 

 

The fair value of these certain financial assets and liabilities was determined using the following inputs at December 28, 2012:

 

		Fair Value Measurements at Reporting Date Using
(In thousands)		Total				Quoted Prices in Active Markets for Identical Assets (Level 1)				Significant Other Observable Inputs (Level 2)				Significant Unobservable Inputs (Level 3)
Assets
Money market
securities (1)		$	49,134			$	49,134			$	-			$	-
Fixed income available
for sale securities (2)			20,881				-				20,881				-
Fixed income trading
securities held in deferred
compensation plan (3)			9,911				9,911				-				-
Equity trading securities
held in deferred
compensation plan (3)			17,178				17,178				-				-
Total		$	97,104			$	76,223			$	20,881			$	-
Liabilities
Deferred compensation
plan (4)			26,984				26,984				-				-
Total		$	26,984			$	26,984			$	-			$	-

 

(1)

Included in cash and cash equivalents on the Company’s consolidated balance sheet.

(2)

Included in short-term investments on the Company’s consolidated balance sheet.

(3)

Included in other current assets and deferred compensation plan assets on the Company’s consolidated balance sheet.

(4)

Included in accrued liabilities and deferred compensation on the Company’s consolidated balance sheet.

 

Fixed income available-for-sale securities as of March 29, 2013 and December 28, 2012 represent primarily obligations of state and local government agencies. Fixed income and equity trading securities represent mutual funds held in the Company’s deferred compensation plan. See Note 6 for additional information about the Company’s deferred compensation plan.

 

As of March 29, 2013, the Company held state and municipal bonds with a fair value of $9,541,000 and an amortized cost of $9,522,000. The unrealized gain recorded in accumulated other comprehensive income was $19,000. There were no securities in a continuous unrealized loss position for more than twelve months. As of March 29, 2013, all available-for-sale securities had maturities of less than one year.

 

As of December 28, 2012, the Company held state and municipal bonds with a fair value of $20,881,000 and an amortized cost of $20,841,000.

 

At March 29, 2013 and December 28, 2012, the Company did not have any assets or liabilities valued using significant unobservable inputs.

 

The following financial instruments are not measured at fair value on the Company's consolidated balance sheet at March 29, 2013 and December 28, 2012, but require disclosure of their fair values: accounts receivable, other assets and accounts payable. The estimated fair value of such instruments at March 29, 2013 and December 28, 2012 approximates their carrying value as reported on the consolidated balance sheet. The fair values of such financial instruments are determined using the income approach based on the present value of estimated future cash flows. There have been no changes in the Company’s valuation technique during fiscal 2013. The fair value of all of these instruments would be categorized as Level 2 of the fair value hierarchy.

 

 

There were no other-than-temporary impairments or credit losses related to available-for-sale securities during the quarters ended March 29, 2013 and March 30, 2012.

 

Note 3: Net Income Per Share

 

Basic per share amounts are computed using the weighted-average number of common shares outstanding during the period. Diluted per share amounts are calculated using the weighted-average number of common shares outstanding during the period and, when dilutive, the weighted-average number of potential common shares from the issuance of common stock to satisfy outstanding restricted stock units and the exercise of outstanding options to purchase common stock using the treasury stock method.

 

The following schedule reconciles the shares used to calculate basic and diluted net income per share:

 

		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012
Shares used in basic per share computation			13,667				13,859
Effect of dilutive common stock options outstanding			76				176
Effect of dilutive restricted stock units outstanding			382				384
Shares used in diluted per share computation			14,125				14,419

 

There were no options excluded from the diluted per share calculations for the three months ended March 29, 2013. Common stock options to purchase 14,011 shares were excluded from the diluted per share calculation for the three months ended March 30, 2012 due to their antidilutive effect. The weighted-average exercise price for the antidilutive shares was $48.27 for the three months ended March 30, 2012.

 

Note 4: Stock-Based Compensation

 

Restricted Stock Units

 

Restricted stock unit grants are designed to attract and retain employees, and to better align employee interests with those of the Company’s stockholders. For a select group of employees, up to 40% of their annual bonus is settled with fully vested restricted stock unit awards. Under these fully vested restricted stock unit awards, the holder of each award has the right to receive one share of the Company’s common stock for each fully vested restricted stock unit four years from the date of grant. Each individual who receives a fully vested restricted stock unit award is also granted a matching number of unvested restricted stock unit awards. Unvested restricted stock unit awards are also granted for select new hires and promotions. These unvested restricted stock unit awards generally cliff vest four years from the date of grant, at which time the holder of each award will have the right to receive one share of the Company’s common stock for each restricted stock unit award provided the holder of each award has met certain employment conditions. In the case of retirement at 59½ years or older, all unvested restricted stock unit awards will continue to vest, provided that the holder of each award does all consulting work through the Company and does not become an employee for a past or present client, beneficial party or competitor of the Company.

 

The value of these restricted stock unit awards is determined based on the market price of the Company’s common stock on the date of grant. The value of fully vested restricted stock unit awards issued is recorded as a reduction to accrued bonuses. The portion of bonus expense that the Company expects to settle with fully vested restricted stock unit awards is recorded as stock-based compensation during the period the bonus is earned. The Company recorded stock-based compensation expense associated with accrued bonus awards of $1,513,000 and $1,474,000 during the three months ended March 29, 2013 and March 30, 2012, respectively. The value of the unvested restricted stock unit awards granted is recognized on a straight-line basis over the shorter of the four-year vesting period or the period between the grant date and the date the award recipient turns 59½. If the award recipient is 59½ years or older on the date of grant, the value of the entire award is expensed upon grant. The Company recorded stock-based compensation expense associated with the unvested restricted stock unit awards of $3,158,000 and $2,831,000 during the three months ended March 29, 2013 and March 30, 2012, respectively.

 

 

Stock Options

 

Stock options are granted for terms of ten years and generally vest 25% per year over a four-year period from the grant date. For options granted on or after January 1, 2012, all unvested stock option awards will continue to vest in the case of retirement at 59½ or older, provided that the holder of each award does all consulting work through the Company and does not become an employee for a past or present client, beneficial party or competitor of the Company. The Company grants options at exercise prices equal to the fair value of the Company’s common stock on the date of grant. The Company recorded stock-based compensation expense of $620,000 and $152,000 during the three months ended March 29, 2013 and March 30, 2012, respectively, associated with stock option grants.

 

The Company uses the Black-Scholes option-pricing model to determine the fair value of options granted. The determination of the fair value of stock-based awards on the date of grant using an option-pricing model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables. These variables include expected stock price volatility over the term of the award, actual and projected employee stock option exercise behaviors, the risk-free interest rate and expected dividends.

 

The Company used historical exercise and post-vesting forfeiture and expiration data to estimate the expected term of options granted. The historical volatility of the Company’s common stock over a period of time equal to the expected term of the options granted was used to estimate expected volatility. The risk-free interest rate used in the option-pricing model was based on United States Treasury zero-coupon issues with remaining terms similar to the expected term on the options. The Company is required to estimate forfeitures at the time of grant and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. Historical data was used to estimate pre-vesting option forfeitures and stock-based compensation expense was recorded only for those awards that are expected to vest. All share-based payment awards are recognized on a straight-line basis over the requisite service periods of the awards.

 

Note 5: Treasury Stock

 

On May 25, 2011, the Company’s Board of Directors authorized $35 million for the repurchase of the Company’s common stock. On February 9, 2012, the Company’s Board of Directors authorized an additional $35 million for the repurchase of the Company’s common stock. On February 15, 2013, the Company’s Board of Directors authorized an additional $35 million for the repurchase of the Company’s common stock.

 

The Company repurchased 229,433 shares of its common stock for $11,676,000 during the three months ended March 29, 2013.  The Company repurchased 84,174 shares of its common stock for $4,033,000 during the three months ended March 30, 2012.  As of March 29, 2013, the Company had remaining authorization under its stock repurchase plans of $44,335,000 to repurchase shares of common stock.

 

The Company reissued 241,137 shares of its treasury stock with a cost of approximately $4,469,000 to settle restricted stock unit awards, stock options and purchases under the Employee Stock Purchase Plan during the three months ended March 29, 2013.  The Company reissued 241,653 shares of its treasury stock with a cost of approximately $6,377,000 to settle restricted stock unit awards, stock options and purchases under the Employee Stock Purchase Plan during the three months ended March 30, 2012.

 

 

Note 6: Deferred Compensation Plan

 

The Company maintains a nonqualified deferred compensation plan for the benefit of a select group of highly compensated employees. Under this plan, participants may elect to defer up to 100% of their compensation. Company assets that are earmarked to pay benefits under the plan are held in a rabbi trust and are subject to the claims of the Company’s creditors. As of March 29, 2013 and December 28, 2012, the invested amounts under the plan totaled $33,986,000 and $27,089,000, respectively. These assets are classified as trading securities and are recorded at fair market value with changes recorded as adjustments to other income and expense.

 

As of March 29, 2013 and December 28, 2012, vested amounts due under the plan totaled $33,894,000 and $26,984,000, respectively. Changes in the liability are recorded as adjustments to compensation expense. During the three months ended March 29, 2013 and March 30, 2012, the Company recognized compensation expense of $2,066,000 and $1,488,000, respectively, as a result of changes in the market value of the trust assets with the same amount being recorded as other income, net.

 

Note 7: Supplemental Cash Flow Information

 

The following is supplemental disclosure of cash flow information:

 

		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012
Cash paid during period:
Income taxes		$	623			$	361
Non-cash investing and financing activities:
Unrealized (loss) gain on short-term investments		$	(12	)		$	26
Vested stock unit awards issued to settle accrued bonuses		$	5,807			$	5,343
Stock repurchases payable to broker		$	694			$	513

 

Note 8: Accounts Receivable, Net

 

At March 29, 2013 and December 28, 2012, accounts receivable, net, was comprised of the following:

 

		March 29,				December 28,
(In thousands)		2013				2012
Billed accounts receivable		$	52,063			$	54,653
Unbilled accounts receivable			31,128				33,374
Allowance for doubtful accounts			(2,639	)			(2,666	)
Total accounts receivable, net		$	80,552			$	85,361

 

 

 

 

Note 9: Segment Reporting

 

The Company has two operating segments based on two primary areas of service. The Engineering and other scientific operating segment is a broad service group providing technical consulting in different practices primarily in the areas of engineering and technology development. The Environmental and health operating segment provides services in the area of environmental, epidemiology and health risk analysis. This operating segment provides a wide range of consulting services relating to environmental hazards and risks and the impact on both human health and the environment.

 

Segment information for the three months ended March 29, 2013 and March 30, 2012 follows:

 

Revenues
		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012
Engineering and other scientific		$	53,323			$	51,717
Environmental and health			19,337				20,208
Total revenues		$	72,660			$	71,925

 

Operating income
		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012
Engineering and other scientific		$	16,874			$	14,933
Environmental and health			5,580				6,784
Total segment operating income			22,454				21,717
Corporate operating expense			(11,603	)			(9,901	)
Total operating income		$	10,851			$	11,816

 

Capital Expenditures
		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012
Engineering and other scientific		$	1,361			$	478
Environmental and health			38				143
Total segment capital expenditures			1,399				621
Corporate capital expenditures			560				673
Total capital expenditures		$	1,959			$	1,294

 

 

Depreciation and Amortization
		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012
Engineering and other scientific		$	699			$	684
Environmental and health			74				68
Total segment depreciation and amortization			773				752
Corporate depreciation and amortization			376				392
Total depreciation and amortization		$	1,149			$	1,144

 

No single customer comprised more than 10% of the Company’s revenues during the three months ended March 29, 2013 and March 30, 2012. No single customer comprised more that 10% of the Company’s accounts receivable at March 29, 2013. Agencies of the U.S. federal government comprised 11% of the Company’s accounts receivable at December 28, 2012.

 

Note 10: Goodwill

 

Below is a breakdown of goodwill reported by segment as of March 29, 2013:

 

		Environmental				Engineering and
(In thousands)		and health				other scientific				Total
Goodwill		$	8,099			$	508			$	8,607

 

There were no acquisitions, dispositions, impairments or other changes in the carrying amount of goodwill, nor any changes in the composition of the Company’s reporting units during the three months ended March 29, 2013.

 

Note 11: Contingencies

 

In July of 2008, the Company was served with a writ by a former client. The writ did not articulate a claim. The Company met with the former client in November of 2008 and again in January of 2009 and learned in those discussions of potential claims against the Company arising out of the testimony delivered by one of the Company’s employees. The former client claims that this testimony contributed to an adverse verdict against them. Given the uncertainty as to whether the claimant will choose to pursue one or more claims against the Company, and the nature of the potential claims against the Company, an estimated loss cannot be determined at this time. The Company believes it has a strong defense against all such potential claims and intends to vigorously defend itself.  Further, the Company believes that some of the potential claims would be covered by insurance. Although the Company’s ultimate liability in this matter (if any) cannot be determined, based upon information currently available, the Company believes, after consultation with legal counsel, the ultimate resolution of these potential claims will not have a material adverse effect on its financial condition.

 

The Company is party to a lawsuit arising from the Company’s hiring of employees from another consulting firm. Their former employer alleges that the Company aided and abetted the employees breach of duties owed to their former employer, wrongfully interfered with the former employer’s economic relationships, and breached a software license agreement. The lawsuit also alleges that the Company misappropriated the former employer’s trade secrets and violated unfair trade practice laws. The lawsuit does not allege a specific dollar amount of damages. The case is currently in discovery and no trial date has been set. The Company intends to vigorously defend itself. Although the Company’s ultimate liability in this matter (if any) cannot be determined based on the information currently available, the Company believes, after consultation with legal counsel, the ultimate resolution of this claim will not have a material adverse effect on its financial condition.

 

 

 

In addition to the above matters, the Company is a party to various other legal actions from time to time and may be contingently liable in connection with claims and contracts arising in the normal course of business, the outcome of which the Company believes, after consultation with legal counsel, will not have a material adverse effect on its financial condition. All legal costs associated with litigation are expensed as incurred.

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included herein and with our audited consolidated financial statements and notes thereto for the fiscal year ended December 28, 2012, which are contained in our fiscal 2012 Annual Report on Form 10-K which was filed with the U.S. Securities and Exchange Commission on February 28, 2013.

 

Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended thereto) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Such forward-looking statements are subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. When used in this document the words “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in general and industry specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our fiscal 2012 Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. Due to such uncertainties and risks, you are warned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. The Company does not intend to release publicly any updates or revisions to any such forward-looking statements.

 

Business Overview

 

Exponent, Inc. is an engineering and scientific consulting firm that provides solutions to complex problems. Our multidisciplinary team of scientists, physicians, engineers and business consultants brings together more than 90 different technical disciplines to solve complicated issues facing industry and business today. Our services include analysis of product development, product recall, regulatory compliance, and discovery of potential problems related to products, people or property and impending litigation, as well as the development of highly technical new products.

 

CRITICAL ACCOUNTING ESTIMATES

 

In preparing our unaudited condensed consolidated financial statements, we make assumptions, judgments and estimates that can have a significant impact on our revenue, operating income and net income, as well as on the value of certain assets and liabilities on our consolidated balance sheet. We base our assumptions, judgments and estimates on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions. On a regular basis we evaluate our assumptions, judgments and estimates and make changes accordingly. We believe that the assumptions, judgments and estimates involved in the accounting for revenue recognition and estimating the allowance for doubtful accounts have the greatest potential impact on our consolidated financial statements, so we consider these to be our critical accounting policies. Historically, our assumptions, judgments and estimates relative to our critical accounting policies have not differed materially from actual results. Policies covering revenue recognition and estimating the allowance for doubtful accounts are described in our fiscal 2012 Annual Report on Form 10-K under “Critical Accounting Estimates” and Note 1 (Summary of Significant Accounting Policies) of the Notes to Consolidated Financial Statements.

 

 

RESULTS OF CONSOLIDATED OPERATIONS

 

Executive Summary

 

Revenues for the first quarter of 2013 increased 1% and revenues before reimbursements increased 4% as compared to the same period last year. The increase in revenues before reimbursements was due to an increase in billable hours and an increase in billing rates. We experienced strong demand for our consulting services from a diverse set of clients for both reactive and proactive projects and received some follow-on activities related to several major investigations. This was partially offset by the expected decline in the level of activity for some of these major investigations. In the utility industry, we investigated pipeline failures and helped improve our clients’ integrity management processes. In the consumer electronics industry, we testified in intellectual property cases and evaluated new designs. In the medical device industry, we evaluated claims of product defect and tested new product reliability. In the oil and gas industry, we assessed environmental and health exposures and analyzed new drilling techniques.

 

A decrease in utilization, a decrease in product sales, and increases in other operating and general and administrative expenses resulted in a 3% decrease in net income during the first quarter of 2013 as compared to the same period last year. Diluted earnings per share decreased to $0.56 per share as compared to $0.57 in the same period last year due to the decrease in net income.

 

We remain focused on selectively adding top talent and developing the skills necessary to expand our market position, providing clients with in-depth scientific research and analysis to determine what happened and how to prevent failures or exposures in the future, capitalizing on emerging growth areas, managing other operating expenses, generating cash from operations, maintaining a strong balance sheet and undertaking activities such as share repurchases and dividends to enhance shareholder value. We continue to expect some of our major investigations to step down from their elevated levels of activity as they move through their project life cycle. We also continue to expect a step down in the level of activity in our defense technology development practice due to the constraints on defense spending and reduction of forces in Afghanistan by the United States Government.

 

Overview of the Three Months Ended March 29, 2013

 

During the first quarter of 2013, billable hours increased 1% to 265,000 as compared to 263,000 during the same period last year. The increase in billable hours was due to follow-on activities related to major investigations and continued demand for our proactive and reactive consulting services. Our utilization decreased to 72% during the first quarter of 2013 as compared to 74% during the same period last year due to the anticipated step down in our elevated levels of activity on several major investigations and due to our investment in hiring technical consultants. Technical full-time equivalent employees increased 3% to 708 during the first quarter of 2013 as compared to 686 during the same period last year due to our recruiting and retention efforts. We continue to selectively hire key talent to expand our capabilities. Product sales in defense technology development decreased to $486,000 for the first quarter of 2013 as compared to $2,386,000 during the same period last year due to lower sales of surveillance systems to the United States Army. We continue to expect a significant decrease in the sales of surveillance systems during fiscal 2013 as a result of the reduction of forces in Afghanistan.

 

 

Three Months Ended March 29, 2013 compared to Three Months Ended March 30, 2012

 

Revenues
		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012				Percent Change
Engineering and other scientific		$	53,323			$	51,717				3.1	%
Percentage of total revenues			73.4	%			71.9	%
Environmental and health			19,337				20,208				(4.3	)%
Percentage of total revenues			26.6	%			28.1	%
Total revenues		$	72,660			$	71,925				1.0	%

 

The increase in revenues for our engineering and other scientific segment was due to an increase in billable hours and an increase in billing rates, partially offset by a decrease in product sales in defense technology development. During the first quarter of 2013, billable hours for this segment increased by 2% to 187,000 as compared to 183,000 during the same period last year. The increase in billable hours was due to strong demand for our services in our electrical engineering and computer science, thermal sciences, biomedical engineering, human factors, and engineering management and construction consulting practices. Technical full-time equivalent employees increased 2% to 484 during the first quarter of 2013 as compared to 473 for the same period last year due our continuing recruiting and retention efforts. Utilization increased to 75% during the first quarter of 2013 as compared to 74% during the same period last year. Product sales in defense technology development decreased to $486,000 for the first quarter of 2013 as compared to $2,386,000 during the same period last year due to lower sales of surveillance systems to the United States Army.

 

The decrease in revenues for our environmental and health segment was due to a decrease in billable hours. During the first quarter of 2013, billable hours for this segment decreased by 3% to 78,000 as compared to 80,000 during the same period last year. Utilization decreased to 67% for the first quarter of 2013 as compared to 72% for the same period last year. The decrease in billable hours and utilization was due in part to a step down from the elevated levels of activity on a number of major investigations that engage consultants across many of our environmental and health practices and centers. The decrease in utilization was also due to our investment in hiring experienced consultants. Technical full-time equivalent employees increased by 5% to 224 during the first quarter of 2013 as compared to 213 for the same period last year.

 

Compensation and Related Expenses
		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012				Percent Change
Compensation and related expenses		$	48,562			$	46,175				5.2	%
Percentage of total revenues			66.8	%			64.2	%

 

The increase in compensation and related expenses during the first quarter of 2013 was due to an increase in payroll expense, an increase in stock-based compensation expense and the change in the value of assets associated with our deferred compensation plan. Payroll expense increased $740,000 due to a 3% increase in technical full-time equivalent employees and our annual salary increase on March 31, 2012. Stock-based compensation expense increased $780,000 due to an increase in the value of unvested restricted stock units granted during the first quarter of 2013. During the first quarter of 2013, deferred compensation expense increased $578,000 with a corresponding increase to other income, net, as compared to first quarter of 2012 due to the change in value of assets associated with our deferred compensation plan. This increase consisted of an increase in the value of the plan assets of $2,066,000 during the first quarter of 2013 and an increase in the value of the plan assets of $1,488,000 during the first quarter of 2012. We expect our compensation expense to increase as we selectively add new talent and our annual salary increases take effect at the beginning of the second quarter of 2013.

 

 

Other Operating Expenses
		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012				Percent Change
Other operating expenses		$	6,147			$	5,562				10.5	%
Percentage of total revenues			8.5	%			7.7	%

 

Other operating expenses include facilities-related costs, technical materials, computer-related expenses and depreciation and amortization of property, equipment and leasehold improvements. The increase in other operating expenses during the first quarter of 2013 was due to an increase in occupancy expense of $424,000 and several individually insignificant items associated with the increase in technical full-time equivalent employees. The increase in occupancy expense was due to the continued expansion of our facilities to accommodate the increase in technical full-time equivalent employees. We expect other operating expenses to grow as we selectively add new talent and make investments in our corporate infrastructure.

 

Reimbursable Expenses
		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012				Percent Change
Reimbursable expenses		$	3,668			$	5,455				(32.8	)%
Percentage of total revenues			5.0	%			7.6	%

 

The decrease in reimbursable expenses was primarily due to a decrease in project related costs in our defense technology development practice within our engineering and other scientific segment. The amount of reimbursable expenses will vary from quarter to quarter depending on the nature of our projects.

 

General and Administrative Expenses
		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012				Percent Change
General and administrative expenses		$	3,432			$	2,917				17.7	%
Percentage of total revenues			4.7	%			4.1	%

 

The increase in general and administrative expenses during the first quarter of 2013 was due to an increase in legal expenses of $296,000, an increase in recruiting expenses of $148,000 and several individually insignificant items associated with the increase in technical full-time equivalent employees and our business development activities. The increase in legal expenses was due to an increase in costs associated with legal claims during the first quarter of 2013 as compared to the same period last year. The increase in recruiting costs was due to our efforts to hire experienced consultants. We expect general and administrative expenses to increase as we selectively add new talent, expand our business development efforts and pursue staff development initiatives.

 

Other Income, Net
		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012				Percent Change
Other income, net		$	2,654			$	1,917				38.4	%
Percentage of total revenues			3.7	%			2.7	%

 

Other income, net, consists primarily of interest income earned on available cash, cash equivalents and short-term investments, changes in the value of assets associated with our deferred compensation plan and rental income from leasing space in our Silicon Valley facility. During the first quarter of 2013, other income, net, increased $578,000 with a corresponding increase to deferred compensation expense, as compared to the first quarter in 2012 due to a change in value of assets associated with our deferred compensation plan. This increase consisted of an increase in the value of the plan assets of $2,066,000 during the first quarter of 2013 and an increase in the value of the plan assets of $1,488,000 during the first quarter of 2012. During the first quarter of 2013, rental income increased $93,000 as compared to the same period last year due to an increase in the occupancy rate for rental space in our Silicon Valley facility.

 

 

Income Taxes
		Three Months Ended
(In thousands)		March 29, 2013				March 30, 2012				Percent Change
Income taxes		$	5,529			$	5,532				(0.1	)%
Percentage of total revenues			7.6	%			7.7	%
Effective tax rate			40.9	%			40.3	%

 

The increase in the effective tax rate was primarily due to an increase in non-deductible expenses.

 

LIQUIDITY AND CAPITAL RESOURCES

 

		Three Months Ended
		March 29, 2013				March 30, 2012
Net cash used in operating activities		$	(5,182	)		$	(1,399	)
Net cash provided by (used in) investing activities			9,281				(1,294	)
Net cash used in financing activities			(15,192	)			(3,480	)

 

We financed our business during the first quarter of 2013 through available cash. We invest our excess cash in cash equivalents and short-term investments. As of March 29, 2013, our cash, cash equivalents and short-term investments were $111.0 million compared to $134.1 million at December 28, 2012. We believe our existing balances of cash, cash equivalents and short-term investments will be sufficient to satisfy our working capital needs, capital expenditures, outstanding commitments, stock repurchases, dividends and other liquidity requirements during the next 12 months.

 

Generally, our net cash provided by operating activities is used to fund our day to day operating activities. First quarter operating cash requirements are generally higher due to payment in the first quarter of our annual bonuses accrued during the prior year. Our largest source of operating cash flows is collections from our clients. Our primary uses of cash from operating activities are for employee related expenditures, leased facilities, taxes, and general operating expenses including marketing and travel.

 

Net cash used in operating activities was $5.2 million for the first quarter of 2013 as compared to $1.4 million during the same period last year. The increase in net cash used in operating activities was due to the timing of payments to vendors partially offset by a decrease in accounts receivable.

 

Net cash provided by (used in) investing activities is primarily related to the purchase and sale or maturity of short-term investments.

 

The increase in cash used in financing activities during the first quarter of 2013 as compared to the same period last year was due to an increase in repurchases of our common stock under our stock repurchase programs and payment of our declared dividend.

 

We expect to continue our investing activities, including capital expenditures. Furthermore, cash reserves may be used to repurchase common stock under our stock repurchase programs, pay dividends or strategically acquire professional service firms that are complementary to our business.

 

 

The following schedule summarizes our principal contractual commitments as of March 29, 2013 (in thousands):

 

		Operating
Fiscal		lease				Capital				Purchase
year		commitments				leases				obligations				Total
2013 (remaining portion)		$	5,411			$	36			$	2,673			$	8,120
2014			6,202				48				-				6,250
2015			4,795				-				-				4,795
2016			3,355				-				-				3,355
2017			2,645				-				-				2,645
Thereafter			4,095				-				-				4,095
		$	26,503			$	84			$	2,673			$	29,260

 

We maintain a nonqualified deferred compensation plan for the benefit of a select group of highly compensated employees. Vested amounts due under the plan of $31,377,000 were recorded as a long-term liability on our unaudited condensed consolidated balance sheet at March 29, 2013. Company assets that are earmarked to pay benefits under the plan are held in a rabbi trust and are subject to the claims of our creditors. As of March 29, 2013 invested amounts under the plan of $31,469,000 were recorded as a long-term asset on our unaudited condensed consolidated balance sheet.

 

As permitted under Delaware law, we have agreements whereby we indemnify our officers and directors for certain events or occurrences while the officer or director is, or was, serving at our request in such capacity. The indemnification period covers all pertinent events and occurrences during the officer’s or director’s lifetime. The maximum potential amount of future payments we could be required to make under these indemnification agreements is unlimited; however, we have director and officer insurance coverage that reduces our exposure and enables us to recover a portion of any future amounts paid.

 

We believe that our existing cash, cash equivalents, short-term investments and our anticipated cash flows from operations will be sufficient to meet our anticipated operating requirements for at least the next twelve months.

 

Non-GAAP Financial Measures

 

Regulation G, Conditions for Use of Non-Generally Accepted Accounting Principles ("Non-GAAP") Financial Measures, and other SEC rules and regulations define and prescribe the conditions for use of Non-GAAP financial information. Generally, a Non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. We closely monitor two financial measures, EBITDA and EBITDAS, which meet the definition of Non-GAAP financial measures. We define EBITDA as net income before income taxes, net interest income, depreciation and amortization. We define EBITDAS as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. These measures are used to evaluate our financial results, develop budgets and determine employee compensation. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP. A reconciliation of the Non-GAAP measures to the nearest comparable GAAP measure is set forth below.

 

 

The following table shows EBITDA as a percentage of revenues before reimbursements for the three months ended March 29, 2013 and March 30, 2012:

 

		Three Months Ended
(in thousands, except percentages)		March 29, 2013				March 30, 2012
Revenues before reimbursements		$	68,992			$	66,470
EBITDA		$	14,609			$	14,800
EBITDA as a % of revenues before reimbursements			21.2	%			22.3	%

 

The decrease in EBITDA as a percentage of revenues before reimbursements was primarily due to a decrease in utilization and an increase in other operating and general administrative expenses. Our utilization decreased to 72% during the first quarter of 2013 as compared to 74% during the same period last year due to the anticipated step down in our elevated levels of activity on several major investigations and due to our investment in hiring technical consultants.

 

The following table is a reconciliation of EBITDA and EBITDAS to the most comparable GAAP measure, net income, for the three months ended March 29, 2013 and March 30, 2012:

 

		Three Months Ended
(in thousands)		March 29, 2013				March 30, 2012
Net income		$	7,976			$	8,201
Add back (subtract):
Income taxes			5,529				5,532
Interest income, net			(45	)			(77	)
Depreciation and amortization			1,149				1,144
EBITDA			14,609				14,800
Stock-based compensation			5,291				4,457
EBITDAS		$	19,900			$	19,257

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

We are exposed to interest rate risk associated with our balances of cash, cash equivalents and short-term investments. We manage our interest rate risk by maintaining an investment portfolio primarily consisting of debt instruments with high credit quality and relatively short average effective maturities in accordance with our investment policy. The maximum effective maturity of any issue in our portfolio is 3 years and the maximum average effective maturity of the portfolio cannot exceed 12 months. If interest rates were to instantaneously increase or decrease by 100 basis points, the change in the fair market value of our portfolio of cash equivalents and short-term investments would not have a material impact on our financial statements. We do not use derivative financial instruments in our portfolio. There have not been any material changes during the period covered by this Quarterly Report on Form 10-Q to our interest rate risk exposures, or how these exposures are managed. Notwithstanding our efforts to manage interest rate risk, there can be no assurances that we will be adequately protected against the risks associated with interest rate fluctuations.

 

We are exposed to some foreign currency exchange rate risk associated with our foreign operations. Given the limited nature of these operations, we believe that any exposure is minimal. Currently, we do not employ a foreign currency hedging program to mitigate our foreign currency exchange risk as we believe the risks to date have not been significant.

 

 

Item 4. Controls and Procedures

 

(a) Evaluation of Disclosure Controls and Procedures

 

As required by Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) of the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this quarterly report. Based on that evaluation, the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were effective.

 

We intend to review and evaluate the design and effectiveness of our disclosure controls and procedures on an ongoing basis, to improve our controls and procedures over time and to correct any deficiencies that we may discover in the future. Our goal is to ensure that our senior management has timely access to all material financial and non-financial information concerning our business. While we believe the present design of our disclosure controls and procedures is effective to achieve our goal, future events affecting our business may cause us to significantly modify our disclosure controls and procedures.

 

(b) Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the three month period ended March 29, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

Item 1A. Risk Factors

 

There have been no material changes from risk factors as previously discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 28, 2012.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

The following table provides information on the Company’s repurchases of the Company’s common stock for the three months ended March 29, 2013 (in thousands, except price per share):

 

		Total Number of Shares Purchased				Average Price Paid Per Share				Total Number of Shares Purchased as Part of Publicly Announced Programs				Approximate Dollar Value of Shares That May Yet Be Purchased Under the Programs (1)
December 29 to January 25			-			$	-				-			$	21,011
Additional funds authorized for
share repurchases														$	35,000
January 26 to February 22			110				49.14				110			$	50,621
February 23 to March 29			120				52.50				120			$	44,335
Total			230			$	50.89				230			$	44,335

 

(1)

On May 25, 2011, the Board of Directors authorized $35,000,000 for the repurchase of the Company’s common stock. On February 9, 2012, the Board of Directors authorized an additional $35,000,000 for the repurchase of the Company’s common stock. On February 15, 2013, the Board of Directors authorized an additional $35,000,000 for the repurchase of the Company’s common stock. These plans have no expiration date.

 

 

Item 6. Exhibits

 

(a)

Exhibit Index

 

31.1

Certification of Chief Executive Officer pursuant to Rule 13a – 14(a) under the Securities Exchange Act of 1934.

 

31.2

Certification of Chief Financial Officer pursuant to Rule 13a – 14(a) under the Securities Exchange Act of 1934.

 

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350.

 

32.2

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	EXPONENT, INC.
	(Registrant)
Date: May 3, 2013
	/s/ Paul R. Johnston
	Paul R. Johnston, Ph.D., Chief Executive Officer
	/s/ Richard L. Schlenker
	Richard L. Schlenker, Chief Financial Officer